Health Care

DOJ busts 115 medical professionals in $1.3B fraud case

Hundreds of individuals were charged with health care fraud, including more than 100 doctors and health care professionals, for their role in stealing $1.3 billion from taxpayers, the Department of Justice announced Thursday.

F.D.A. panel endorses first gene-altering therapy for leukemia patients

The Food and Drug Administration has entered a new era in medicine after an FDA advisory panel endorsed a leukemia treatment that could be the first gene-altering therapy available in the U.S. The panel of cancer experts voted 10-0 Wednesday, recommending that the treatment be approved.

Novel leukemia treatment could be 1st US gene therapy

Cancer experts who advise government regulators are reviewing what could be the first gene therapy approved in the U.S. The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp.

The price dilemma over a $16,000 drug

Novartis AG recently discovered that a drug it sells for a group of very rare diseases could be used to treat a much more common ailment. There is just one problem: its $16,000-per-dose price tag.

Charlie Gard: Treatment can prolong life, Dr. Marc Siegel says

The parents of Charlie Gard, an 11-month old terminally ill baby in Britain, want to take their child to America to get treatment for a rare disease which has caused brain damage. But socialized medicine in Britain put the government in charge of the child’s life.